{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-029943","form_type":"8-K","ticker":"LUCD","cik":"0001799011","company_name":"Lucid Diagnostics Inc.","filed_at":"2026-06-24T21:00:31+00:00","discovered_at":"2026-06-24T21:02:31.339209+00:00","generated_at":"2026-06-24T21:03:26.224550+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Lucid Diagnostics shareholders approve increase in authorized common shares from 300M to 400M","bullets":["Amendment approved: 152,941,468 for, 12,113,250 against, 382,419 abstain; effective June 24, 2026.","All three Class B director nominees re-elected: James L. Cox, John R. Palumbo, Ronald M. Sparks.","Ratification of CBIZ CPAs P.C. as independent auditor for FY 2025 approved (161.8M votes for).","Approximately 84.7% of outstanding shares represented at the annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-029943","json":"https://secwatch.observer/filing/0001493152-26-029943.json","markdown":"https://secwatch.observer/filing/0001493152-26-029943.md","text":"https://secwatch.observer/filing/0001493152-26-029943.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799011/000149315226029943/0001493152-26-029943-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799011/000149315226029943/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T21:03:26.224550+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}